SCHEMBL933333

SCHEMBL933333

CCc1csc(CC(=O)NC(Cc2ccccc2NS(=O)(=O)O)c2nc(CC)cs2)n1

nearest known ligand 0.63

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3926173 0.89 PTPRB (0.78) PTPRB
SCHEMBL1287189 0.89 PTPRB (0.78) PTPRB
SCHEMBL933921 0.88 PTPRB (0.79) PTPRB
SCHEMBL468306 0.87 PTPRB (0.61) PTPRB
SCHEMBL932526 0.87 PTPRB (0.78) PTPRB
SCHEMBL1287172 0.86 PTPRB (0.76) PTPRB
SCHEMBL932727 0.86 PTPRB (0.76) PTPRB
SCHEMBL3918111 0.85 PTPRB (0.59) PTPRB
SCHEMBL933887 0.85 PTPRB (0.76) PTPRB
SCHEMBL3920078 0.85 PTPRB (0.77) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2451279-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLS Akebia Therapeutics Inc. (US) 2012-05-16 EP disclosed
WO-2011005330-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR PREVENTING METASTASIS OF CANCER CELLS AKEBIA THERAPEUTICS INC. (US) 2011-01-13 WO disclosed
EP-2038265-A2 HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE The Procter and Gamble Company (US) 2009-03-25 EP disclosed
WO-2008002570-A2 HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THE PROCTER & GAMBLE COMPANY (US) 2008-01-03 WO disclosed